Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 µg QOD in patients with relapsing-remitting multiple sclerosis: A multicenter, randomized, double-blind, parallel-group pilot study
- 30 June 2008
- journal article
- research article
- Published by Elsevier BV in Clinical Therapeutics
- Vol. 30 (6), 1102-1112
- https://doi.org/10.1016/j.clinthera.2008.06.013